This website uses cookies to improve your browsing experience. By continuing to use this site, you consent to our use of cookies. You can manage your cookie preferences in our Cookie Policy.
For years, one assumption in Parkinson’s research has held steady: the longer someone lives with the disease, the further its hallmark pathology, clumps of misfolded…
There have been no new FDA approvals for future Parkinson’s therapies this past month, but that doesn’t mean anything hasn’t happened. A handful of real…